This realignment is part of a broader strategy to enhance focus on the consumer business, which currently contributes 7% to ...

The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.

Mankind Pharma’s consumer products portfolio includes several trusted brands Manforce, HealthOK, Prega News, AcneStar, ...

Deal involves Mankind buying 100 per cent equity in Bharat Serums from PE firm Advent International at an enterprise value of ...

The pharma major has transferred its Over-the-Counter (OTC) business to its subsidiary, Mankind Consumer Products, via a ...

The Competition Commission of India (CCI) has approved Mankind Pharma’s acquisition of Bharat Serums and Vaccines for ₹13,630 ...

Mankind Pharma Ltd. receives regulatory approvals for 100% acquisition of Bharat Serums and Vaccines Ltd. worth ₹13,630 crore ...

The Competition Commission of India (CCI) has approved Mankind Pharma's acquisition of Bharat Serums and Vaccines for Rs ...

The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

Mankind Pharma transfers OTC business to subsidiary, focuses on consumer products, raises funds through debentures and ...

Mankind Pharma will issue non-convertible debentures (NCDs) and commercial papers (CP) worth ₹5,000 crore. These funds will ...

Mankind Pharma plans to raise up to Rs 10,000 crore through non-convertible debentures and commercial papers. The board ...